Quantcast

Latest Organic chemistry Stories

2014-09-02 20:24:44

- Primary efficacy endpoint met with a statistically significant reduction of sIGF-I levels of 26% at the 400mg/week dose (P

2014-09-02 16:25:38

NEWARK, Calif., Sept. 2, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that it intends to offer, subject to market and other conditions, $230 million aggregate principal amount of Convertible Senior Notes due 2021 (the "Notes"). Depomed, Inc. ("Depomed") expects to grant the underwriters in the offering a 30-day option to purchase up to an additional $34.5 million aggregate principal amount of the Notes. Morgan Stanley & Co. LLC and RBC Capital Markets, LLC...

2014-09-02 12:30:19

Report examines deadly trends that created latest heroin scourge; Research to be presented at National PAIN Week conference September 2-6, 2014 BALTIMORE, Sept. 2, 2014 /PRNewswire/ -- Ameritox(SM), the nation's leader in medication monitoring solutions, today released, "A Deadly Trend: Prescription Drugs to Heroin," a research report that provides concrete evidence linking prescription drug abuse to heroin abuse, and examines deadly trends that have created a unique heroin epidemic. The full...

2014-09-02 12:29:39

BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- -- GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients at risk of stroke in everyday clinical practice -- Data from nearly 12,500 patients enrolled in the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent academic research initiative, have illustrated that stroke prevention strategies for atrial...

2014-09-02 08:30:31

Patients at higher risk of kidney problems due to existing diabetes were also evaluated for the effects of warfarin on kidney function RIDGEFIELD, Conn., Sept. 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new post-hoc sub-analysis of the pivotal phase III RE-LY® trial assessing renal function change in patients with non-valvular atrial fibrillation (NVAF) treated with Pradaxa® (dabigatran etexilate mesylate) compared to warfarin. The...

2014-09-01 23:02:05

Caprolactam market research report focuses on the basis of applications, end-user industries, and geography along with forecasting volume, value, & analyzing trends. (http://www.marketsandmarkets.com/Market-Reports/caprolactam-market-108120798.html) (PRWEB) September 01, 2014 The report "Caprolactam Market by Material Type (Engineering Plastics & Fibers), by Application (Textile, Industrial, Carpet, Automotive, Film & Coating, Machinery, E&E, Consumer Goods,...

2014-09-01 23:01:31

The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who allegedly developed Lipitor diabetes injuries after taking the cholesterol-lowering statin drug. New York, NY (PRWEB) September 01, 2014 More than 200 Lipitor lawsuit (http://www.thelipitorlawsuit.com/) filings have been added to a federal litigation that continues to progress in the U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. A federal Case List published on August 15th...

2014-09-01 00:21:00

- VIMPAT® (lacosamide) C-V approved in the U.S. as monotherapy in the treatment of partial-onset seizures in adults with epilepsy(1) BRUSSELS, Sept. 1, 2014 /PRNewswire/ -- 0700 (CEST) - regulated information -- UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VIMPAT(®) (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older.(1) This is a new...

2014-08-31 23:01:19

Harbor Village Florida Comments on New Street Drug Showing to be Much More Powerful Than Heroin USA (PRWEB) August 31, 2014 According to an article posted in Medical News Today (8/21), entitled Emerging Street Drug Fifteen Times Stronger than Heroin, a new opiate has begun to hit the streets of America which is fifteen times more potent than heroin. Known as acetyl fentanyl, this opiate is a non-medical use drug that has been linked to many overdoses and emergency room visits among opiate...

2014-08-29 23:06:02

DEA’s announcement comes after a recommendation last year concerning the potent combination drug products. Port Washington, New York (PRWEB) August 29, 2014 Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured by medications reports that the Drug Enforcement Administration (DEA) has announced new regulations for all hydrocodone combination products. According to a Regulatory Affairs Professionals Society (RAPS)...


Latest Organic chemistry Reference Libraries

Organometallics
2012-05-17 15:18:17

Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....

Synthetic Metals
2012-05-17 14:54:38

Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...

More Articles (2 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related